Avanos Medical Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 6.67, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Avanos Medical Inc in Mar 31 2026 quarter, has decreased to 55 days, compared to 56 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 245 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 0 to 1977.

What is Receivable Turnover Ratio?
What is Avanos Medical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AVNS Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-1.72 %	-21.84 %	-15.47 %	-10.41 %	-20.18 %
Y / Y Revenue Change	9.23 %	0.72 %	4.18 %	1.46 %	0.6 %
Receivable Turnover Ratio (TTM)	6.67	6.5	6.07	5.76	5.59
AVNS's Total Ranking	# 1977	# 0	# 0	# 0	# 0
Accounts Receivable average collection period days	55	56	60	63	65
Seq. Receivable Change	-0.77 %	-6.91 %	1.18 %	5.15 %	-21.08 %
Seq. Revenue Change	0.72 %	2.2 %	1.67 %	4.38 %	-7.13 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 92
Healthcare Sector	# 246
Overall Market	# 1977

Receivable Turnover Ratio Statistics
High	Average	Low
8.61	5.08	-3.75
(Jun 30 2017)		(Sep 30 2015)

AVNS Company Profile • Back to AVNS Efficiency Comparisons • Compare AVNS Receivables Turnover Ratio to its Competitors

Financial Statements
Avanos Medical Inc 's Accounts Receivable	$ 103 Millions	Visit AVNS's Balance sheet
Avanos Medical Inc 's Sales TTM	$ 714 Millions	Visit AVNS's Income Statement
Sources of AVNS's Revenues		Visit AVNS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVNS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVNS's Growth Rates	AVNS's Roa	AVNS's Inventory Turnover Ratio	AVNS's Dividend Comparisons
AVNS's Profitability Ratios	AVNS's Roi	AVNS's Asset Turnover Ratio	AVNS's Dividend Growth
AVNS's Valuation Ratios	AVNS's Roe	AVNS's Financial Strength Ratios	AVNS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Premier Air Charter Holdings Inc	18.93	$ 33.205 Millions	$ 1.754 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Voyager Therapeutics Inc	17.99	$ 36.494 Millions	$ 2.029 Millions
China Pharma Holdings Inc	17.15	$ 3.992 Millions	$ 0.233 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Arvinas Inc	15.15	$ 89.400 Millions	$ 5.900 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Vaxart Inc	14.88	$ 255.609 Millions	$ 17.175 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
10x Genomics Inc	14.18	$ 637.614 Millions	$ 44.950 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Skinhealth Systems Inc	13.48	$ 295.223 Millions	$ 21.902 Millions
Lftd Partners Inc	13.33	$ 36.955 Millions	$ 2.773 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Innoviva Inc	13.13	$ 394.185 Millions	$ 30.016 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Reshape Lifesciences Inc	12.79	$ 2.421 Millions	$ 0.189 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions

Date modified: 2026-09-26T07:01:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.